Quantitative Image Analysis of Human Epidermal Growth Factor Receptor 2 Immunohistochemistry for Breast Cancer: Guideline From the College of American Pathologists.

* Context.--Advancements in genomic, computing, and imaging technology have spurred new opportunities to use quantitative image analysis (QIA) for diagnostic testing. Objective.--To develop evidence-based recommendations to improve accuracy, precision, and reproducibility in the interpretation of hu...

Descripción completa

Detalles Bibliográficos
Publicado en:Archives of Pathology & Laboratory Medicine Vol. 143; no. 10; pp. 1180 - 1196
Autores principales: Bui, Marilyn M., Riben, Michael W., Allison, Kimberly H., Chlipala, Elizabeth, Colasacco, Carol, Kahn, Andrea G., Lacchetti, Christina, Madabhushi, Anant, Pantanowitz, Liron, Salama, Mohamed E., Stewart, Rachel L., Thomas, Nicole E., Tomaszewski, John E., Hammond, M. Elizabeth
Formato: pictorial practice guidelines research systematic review tables/charts Journal Article
Publicado: College of American Pathologists Oct2019
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=139005602&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 139005602
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00039985
        1FS
      jtl: Archives of Pathology & Laboratory Medicine
      issn: 00039985
      maglogo: N
    pubinfo:
      dt: Oct2019
      vid: 143
      iid: 10
      pid: 2550
      pub: College of American Pathologists
      place: Northfield, Illinois
    artinfo:
      ui:
        139005602
        139005602
        139005602
        10.5858/arpa.2018-0378-CP
        139005602
      ppf: 1180
      ppct: 16
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Quantitative Image Analysis of Human Epidermal Growth Factor Receptor 2 Immunohistochemistry for Breast Cancer: Guideline From the College of American Pathologists.
      aug:
        au:
          Bui, Marilyn M.
          Riben, Michael W.
          Allison, Kimberly H.
          Chlipala, Elizabeth
          Colasacco, Carol
          Kahn, Andrea G.
          Lacchetti, Christina
          Madabhushi, Anant
          Pantanowitz, Liron
          Salama, Mohamed E.
          Stewart, Rachel L.
          Thomas, Nicole E.
          Tomaszewski, John E.
          Hammond, M. Elizabeth
        affil: Department of Anatomic Pathology, H. Lee Moffitt Cancer Center, Tampa, Florida
      sug:
        subj:
          Breast Neoplasms Diagnosis
          Image Processing, Computer Assisted Methods
          Immunohistochemistry
          Receptors, Cell Surface
          Pathologists
          Sensitivity and Specificity
          Epidermal Growth Factor Receptors
          Human
          Quantitative Studies
          Precision
          Scientists
          Feedback
          Consensus
          Quality Assurance
          Systematic Review
      ab: * Context.--Advancements in genomic, computing, and imaging technology have spurred new opportunities to use quantitative image analysis (QIA) for diagnostic testing. Objective.--To develop evidence-based recommendations to improve accuracy, precision, and reproducibility in the interpretation of human epidermal growth factor receptor 2 (HER2) immunohistochemistry (IHC) for breast cancer where QIA is used. Design.--The College of American Pathologists (CAP) convened a panel of pathologists, histotechnologists, and computer scientists with expertise in image analysis, immunohistochemistry, quality management, and breast pathology to develop recommendations for QIA of HER2 IHC in breast cancer. A systematic review of the literature was conducted to address 5 key questions. Final recommendations were derived from strength of evidence, open comment feedback, expert panel consensus, and advisory panel review. Results.--Eleven recommendations were drafted: 7 based on CAP laboratory accreditation requirements and 4 based on expert consensus opinions. A 3-week open comment period received 180 comments from more than 150 participants. Conclusions.--To improve accurate, precise, and reproducible interpretation of HER2 IHC results for breast cancer, QIA and procedures must be validated before implementation, followed by regular maintenance and ongoing evaluation of quality control and quality assurance. HER2 QIA performance, interpretation, and reporting should be supervised by pathologists with expertise in QIA.
      pubtype: Academic Journal
      doctype:
        pictorial
        practice guidelines
        research
        systematic review
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N